Fagron NV/€FAGR
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Fagron NV
Fagron NV is a pharmaceutical company specializing in pharmaceutical compounding, providing personalized medical solutions to hospitals, pharmacies, clinics, and patients across more than 30 countries. The company operates through three segments: Essentials, offering pharmaceutical raw materials and equipment; Brands, developing innovative compounding concepts and formulations; and Compounding Services, delivering ready-to-use medications from its sterile and non-sterile facilities. Founded in 1990 in Rotterdam, the Netherlands, Fagron has expanded its operations globally, with its registered office in Nazareth, Belgium, and operational headquarters in Rotterdam. The company's strategic focus on innovation and quality has enabled it to establish a significant presence in the pharmaceutical compounding market.
Ticker
€FAGR
Sector
Primary listing
BSE
Employees
3,989
Headquarters
Website
Fagron NV Metrics
BasicAdvanced
€1.5B
17.76
€1.17
0.24
€0.25
1.18%
Price and volume
Market cap
€1.5B
Beta
0.24
52-week high
€22.85
52-week low
€14.97
Average daily volume
1.4K
Dividend rate
€0.25
Financial strength
Current ratio
1.765
Quick ratio
1.057
Long term debt to equity
77.498
Total debt to equity
80.022
Dividend payout ratio (TTM)
28.53%
Interest coverage (TTM)
7.16%
Profitability
EBITDA (TTM)
158.248
Gross margin (TTM)
45.75%
Net profit margin (TTM)
9.33%
Operating margin (TTM)
15.19%
Effective tax rate (TTM)
22.85%
Revenue per employee (TTM)
€230,000
Management effectiveness
Return on assets (TTM)
8.06%
Return on equity (TTM)
17.53%
Valuation
Price to earnings (TTM)
17.76
Price to revenue (TTM)
1.649
Price to book
3.03
Price to tangible book (TTM)
-44.71
Price to free cash flow (TTM)
17.824
Free cash flow yield (TTM)
5.61%
Free cash flow per share (TTM)
1.166
Dividend yield (TTM)
1.18%
Forward dividend yield
1.18%
Growth
Revenue change (TTM)
11.94%
Earnings per share change (TTM)
9.61%
3-year revenue growth (CAGR)
13.66%
10-year revenue growth (CAGR)
7.28%
3-year earnings per share growth (CAGR)
7.20%
10-year earnings per share growth (CAGR)
-0.13%
3-year dividend per share growth (CAGR)
20.51%
10-year dividend per share growth (CAGR)
-9.97%
Bulls say / Bears say
Fagron reported record first-quarter revenue of €238.7 million, up 14.1% as reported and 12.6% organic growth at CER, reflecting strong performance across all regions and segments. (Reuters)
At Capital Markets Day, Fagron unveiled mid-term targets, including organic revenue CAGR in the high single-digit to low double-digit range and a REBITDA margin near 21% by 2027, reinforcing its long-term growth strategy. (Reuters)
The FDA has recognized Fagron’s corrective actions at its Wichita facility, confirming that recent improvements effectively address prior inspection concerns, underscoring strengthened quality controls. (Reuters)
Revenue growth slowed to 6.4% in Q3 2025, down from double-digit rates earlier in the year, signaling possible difficulties in keeping up momentum. (Reuters)
An FDA Warning Letter issued in December 2024 documented several significant CGMP violations at Fagron's Wichita sterile facility, putting the company at risk for regulatory penalties and reputational harm. (FDA)
Fagron’s debt-to-equity ratio is around 69%, which may restrict financial flexibility and limit opportunities for future investments. (Simply Wall St)
Data summarised monthly by Lightyear AI. Last updated on 9 Oct 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Fagron NV stock?
Fagron NV (FAGR) has a market cap of €1.5B as of October 26, 2025.
What is the P/E ratio for Fagron NV stock?
The price to earnings (P/E) ratio for Fagron NV (FAGR) stock is 17.76 as of October 26, 2025.
Does Fagron NV stock pay dividends?
Yes, the Fagron NV (FAGR) stock pays dividends to shareholders. As of October 26, 2025, the dividend rate is €0.245 and the yield is 1.18%. Fagron NV has a payout ratio of 28.53% on a trailing twelve-month basis.
When is the next Fagron NV dividend payment date?
The next Fagron NV (FAGR) dividend payment date is unconfirmed.
What is the beta indicator for Fagron NV?
Fagron NV (FAGR) has a beta rating of 0.24. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.